152 related articles for article (PubMed ID: 36064796)
21. Tumor-stromal cell interaction under hypoxia increases the invasiveness of pancreatic cancer cells through the hepatocyte growth factor/c-Met pathway.
Ide T; Kitajima Y; Miyoshi A; Ohtsuka T; Mitsuno M; Ohtaka K; Koga Y; Miyazaki K
Int J Cancer; 2006 Dec; 119(12):2750-9. PubMed ID: 16998831
[TBL] [Abstract][Full Text] [Related]
22. Contribution of environment and genetics to pancreatic cancer susceptibility.
Hocevar BA; Kamendulis LM; Pu X; Perkins SM; Wang ZY; Johnston EL; DeWitt JM; Li L; Loehrer PJ; Klaunig JE; Chiorean EG
PLoS One; 2014; 9(3):e90052. PubMed ID: 24651674
[TBL] [Abstract][Full Text] [Related]
23. The TERT hypermethylated oncologic region predicts recurrence and survival in pancreatic cancer.
Faleiro I; Apolónio JD; Price AJ; De Mello RA; Roberto VP; Tabori U; Castelo-Branco P
Future Oncol; 2017 Oct; 13(23):2045-2051. PubMed ID: 29019414
[TBL] [Abstract][Full Text] [Related]
24. Molecular classification of neoplasms of the pancreas.
Hruban RH; Adsay NV
Hum Pathol; 2009 May; 40(5):612-23. PubMed ID: 19362631
[TBL] [Abstract][Full Text] [Related]
25. Cancer: A suppression switch.
Starobinets H; Debnath J
Nature; 2013 Dec; 504(7479):225-6. PubMed ID: 24305045
[No Abstract] [Full Text] [Related]
26. Molecular pathogenesis of pancreatic cancer.
Maitra A; Kern SE; Hruban RH
Best Pract Res Clin Gastroenterol; 2006 Apr; 20(2):211-26. PubMed ID: 16549325
[TBL] [Abstract][Full Text] [Related]
27. The pathology and genetics of metastatic pancreatic cancer.
Yachida S; Iacobuzio-Donahue CA
Arch Pathol Lab Med; 2009 Mar; 133(3):413-22. PubMed ID: 19260747
[TBL] [Abstract][Full Text] [Related]
28. Carcinogenesis of pancreatic adenocarcinoma: precursor lesions.
Gnoni A; Licchetta A; Scarpa A; Azzariti A; Brunetti AE; Simone G; Nardulli P; Santini D; Aieta M; Delcuratolo S; Silvestris N
Int J Mol Sci; 2013 Sep; 14(10):19731-62. PubMed ID: 24084722
[TBL] [Abstract][Full Text] [Related]
29. Progression model for pancreatic cancer.
Hruban RH; Goggins M; Parsons J; Kern SE
Clin Cancer Res; 2000 Aug; 6(8):2969-72. PubMed ID: 10955772
[No Abstract] [Full Text] [Related]
30. Pancreatic cancer in 2017: Rebooting pancreatic cancer knowledge and treatment options.
Semaan A; Maitra A
Nat Rev Gastroenterol Hepatol; 2018 Feb; 15(2):76-78. PubMed ID: 29317774
[No Abstract] [Full Text] [Related]
31. Autophagy, p53, and pancreatic cancer.
Iacobuzio-Donahue CA; Herman JM
N Engl J Med; 2014 Apr; 370(14):1352-3. PubMed ID: 24693896
[No Abstract] [Full Text] [Related]
32. Pancreatic cancer: pathobiology, treatment options, and drug delivery.
Li J; Wientjes MG; Au JL
AAPS J; 2010 Jun; 12(2):223-32. PubMed ID: 20198462
[TBL] [Abstract][Full Text] [Related]
33. Proteomic and genomic profiling of pancreatic cancer.
Ansari D; Torén W; Zhou Q; Hu D; Andersson R
Cell Biol Toxicol; 2019 Aug; 35(4):333-343. PubMed ID: 30771135
[TBL] [Abstract][Full Text] [Related]
34. Modulation of microRNAs by curcumin in pancreatic cancer.
Simental-Mendía LE; Sahebkar A
Clin Nutr; 2016 Dec; 35(6):1585. PubMed ID: 27663544
[No Abstract] [Full Text] [Related]
35. Genotype Adjusts Fibrotic Phenotype to Drive Pancreatic Cancer.
Cancer Discov; 2016 Jun; 6(6):572. PubMed ID: 27150537
[TBL] [Abstract][Full Text] [Related]
36. Pancreatic neuroendocrine tumors: pathologic and molecular characteristics.
Shi C; Klimstra DS
Semin Diagn Pathol; 2014 Nov; 31(6):498-511. PubMed ID: 25441311
[TBL] [Abstract][Full Text] [Related]
37. Killer genes in pancreatic cancer therapy.
Fogar P; Greco E; Basso D; Navaglia F; Plebani M; Pedrazzoli S
Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(1):61-76. PubMed ID: 16171565
[TBL] [Abstract][Full Text] [Related]
38. Molecular pathology of pancreatic cancer: implications for molecular targeting therapy.
Furukawa T
Clin Gastroenterol Hepatol; 2009 Nov; 7(11 Suppl):S35-9. PubMed ID: 19896096
[TBL] [Abstract][Full Text] [Related]
39. [Pancreatic cancer. Molecular and surgical pathology].
Tannapfel A
Pathologe; 2010 Oct; 31 Suppl 2():225-8. PubMed ID: 20669020
[TBL] [Abstract][Full Text] [Related]
40. miR-221/222 induces pancreatic cancer progression through the regulation of matrix metalloproteinases.
Xu Q; Li P; Chen X; Zong L; Jiang Z; Nan L; Lei J; Duan W; Zhang D; Li X; Sha H; Wu Z; Ma Q; Wang Z
Oncotarget; 2015 Jun; 6(16):14153-64. PubMed ID: 25883224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
